Cervical Intraepithelial Neoplasia Clinical Trials

A listing of Cervical Intraepithelial Neoplasia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 98 clinical trials
Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy

The proposed randomized control trial will evaluate auricular point acupressure (APA) on chemotherapy-induced neuropathy (CIN), rigorously considering point specificity and placebo effects by

Accepts healthy volunteers
  • 0 views
  • 12 Nov, 2021
  • 1 location
  • 7 views
  • 17 Sep, 2022
  • 15 locations
Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments (ORGANOIDES)

Human papilloma virus (HPV) is responsible of the most common sexually transmitted infection. It can cause severe cancer lesions, of the cervix, vulva, vagina, penis and oropharynx. The International Agency for Cancer Research of World Health Organization (WHO) classified a dozen of HPV related high-risk cancer types, and recognized cervical …

dysplasia
papilloma
human papilloma virus vaccine
lab tests
vaginal biopsy
  • 100 views
  • 21 Apr, 2022
  • 1 location
Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

Phase II clinical trial, monocentric, not controlled, in patients with high grade cervical intraepithelial lesions. A total of 62 patients with a diagnosis of CIN II, III or carcinoma in situ

carcinoma
cone biopsy
cervical intraepithelial neoplasia grade 2
ocoxin
human papillomavirus
  • 19 views
  • 24 Jul, 2022
  • 1 location
Papilocare : Effects on Regression of Histologically Confirmed Cervical Intraepithelial Lesions 1 and Tolerance

clinical trial comparing the regression rate after 12 months of histologically confirmed cervical intraepithelial lesions 1 in 2 parallel groups. One group using the vaginal gel Papilocare for 6 months and one group without any treatment.

smear
hpv vaccine
human papillomavirus
low-grade squamous intraepithelial lesion
colposcopy
  • 4 views
  • 18 Nov, 2021
  • 1 location
A Phase I/II Trial of T Cell Receptor Gene Therapy Targeting HPV-16 E7 for HPV-Associated Cancers

Background Human papillomavirus (HPV) can cause cervical, throat, anal, and genital cancers. Cancers caused by HPV have a HPV protein called E7 inside of their cells. In this new therapy, researchers take a person s blood, remove certain white blood cells, and insert genes that make them to target cancer …

filgrastim
platelet count
neutrophil count
metastasis
chemotherapy drugs
  • 370 views
  • 16 Sep, 2022
  • 1 location
Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. (Vulvar-AIN)

Almost half of all women will develop an HPV infection in their lifetime. While most infections are naturally asymptomatic or cleared by the immune system, some persist and can lead to the development of cervical, vulvar, or anal lesions and eventually cancer. Screening regimens for these lesions are currently only …

smear
dysplasia
hpv vaccine
vulvar dysplasia
human papilloma virus vaccine
  • 0 views
  • 01 Mar, 2022
  • 1 location
Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms. (RIP-CI-AKI)

The use of imaging is increasing in clinical practice, either for diagnosis or intervention. In these imaging processes, contrast medium (CM) is widely used. However, CM administration can induce contrast-induced nephropathy (CI-AKI). CI-AKI is the third most common cause of renal insufficiency, and its incidence varies from 2% to 50% …

  • 0 views
  • 02 May, 2022
  • 1 location
Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma

Prospective, multicenter, single-arm, open label, interventional study evaluating adoptive cell therapy (ACT) with autologous tumor infiltrating lymphocytes (TIL) infusion (LN-145) followed by IL-2 after a non-myeloablative (NMA) lymphodepletion preparative regimen for the treatment of patients with recurrent, metastatic, or persistent cervical carcinoma

carcinoma
adenocarcinoma
cervical carcinoma
cervical adenocarcinoma
carboplatin
  • 1113 views
  • 28 Jan, 2022
  • 20 locations
Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer

This clinical trial studies the feasibility of using hypo-fractionated radiotherapy for the treatment of cervical or endometrial cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects.

adenocarcinoma
cancer
tumor cells
hysterectomy
  • 0 views
  • 07 Jan, 2022
  • 1 location